News & Events

Year in Review and 2022 updates with António Parada, CEO

CEO, António Parada, was invited by TV channel RTP to review the companies growth in 2021 and preview exciting announcements on what lies ahead for FairJourney BiologicsFlow Eighteen38 and IONTAS in 2022.

Some highlights include:

  • 5 Million Euro investment into new equipment for Flow Eighteen38 and protein production capabilities
  • Offering of Reagent antibodies that comply with new EU directives (discover more here)
  • Successful completion of 4 international site expansions
  • New offices and employees dedicated in Boston, USA
  • New Technologies to be unveiled in 2022 at IONTAS from John McCafferty
  • Cold storage offering to new and existing partners (discover more here)
  • The announcement of THE ANTIBODY SERIES 2022 (join the event here)

And more exciting news. Watch the full video interview below.

Learn more about us

FairJourney Biologics is a leading biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma. The Company’s significant expertise in phage display technology, combined with a diverse approach to generating both immune and naïve antibody libraries have contributed to a market leading 99%+ project success rate.

Get in touch with us
This site uses cookies to provide you with a great user experience. By using our website, you accept our use of cookies.